相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug resistance and Cancer stem cells
Yuan Li et al.
CELL COMMUNICATION AND SIGNALING (2021)
Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study
Beatrice Aramini et al.
Oncotarget (2020)
Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial
Ching-Yang Wu et al.
DIAGNOSTICS (2020)
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?
Valentina Masciale et al.
Oncotarget (2020)
Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies
Swapnil Rajurkar et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer
Rilan Bai et al.
FRONTIERS IN ONCOLOGY (2020)
The current treatment landscape in the UK for stage III NSCLC
Matthew Evison
BRITISH JOURNAL OF CANCER (2020)
Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities
Chiara Lazzari et al.
DIAGNOSTICS (2020)
Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature
Leonardo Muratori et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2020)
Tumor Plasticity and Resistance to Immunotherapy
Lucas A. Horn et al.
TRENDS IN CANCER (2020)
Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects
Anoop K. Yadav et al.
STEM CELL REVIEWS AND REPORTS (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
Maria Gabriela Fernandes et al.
CANCERS (2019)
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
Giuseppe Vassalli
STEM CELLS INTERNATIONAL (2019)
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing
Kumar Prabhash et al.
ADVANCES IN THERAPY (2019)
Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
Ernestina M. de Francesco et al.
BIOCHEMICAL JOURNAL (2018)
The effectiveness of the follow-up of patients after surgery due to cancer of the head and neck
Joanna Jackowska et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
Hiroshi Maeda et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
Karolina Orywal et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
Lauren MacDonagh et al.
ONCOTARGET (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
Mauricio Rodriguez-Torres et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
Young Kwang Chae et al.
CLINICAL LUNG CANCER (2016)
Optimising treatment for post-operative lung cancer recurrence
Dragan Subotic et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Understanding Genotype-Phenotype Effects in Cancer via Network Approaches
Yoo-Ah Kim et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Current practices and guidelines for clinical next-generation sequencing oncology testing
Samuel P. Strom et al.
Cancer Biology & Medicine (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis
Dong Wei et al.
HEART LUNG AND CIRCULATION (2015)
Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma
Raphael Bueno et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Aldehyde dehydrogenases in cancer: an opporunity for biomaker and drug development?
Klaus Pors et al.
DRUG DISCOVERY TODAY (2014)
Prognosis of recurrent non-small cell lung cancer following complete resection
Hidefumi Sasaki et al.
ONCOLOGY LETTERS (2014)
Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer
Christoph Kahlert et al.
BMC CANCER (2011)
Assessment of the Evolution of Cancer Treatment Therapies
Manuel Arruebo et al.
Cancers (2011)
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
Shaheen S. Sikandar et al.
CANCER RESEARCH (2010)
Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
James P. Sullivan et al.
CANCER RESEARCH (2010)
Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
Malcolm R. Alison et al.
JOURNAL OF PATHOLOGY (2010)
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang et al.
MOLECULAR CANCER RESEARCH (2009)
Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence
J-J Hung et al.
THORAX (2009)
Cancer stem cells - Models, mechanisms and implications for improved treatment
Jiangbing Zhou et al.
CELL CYCLE (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Aldehyde Dehydrogenase as a Marker for Stem Cells
Jan S. Moreb
CURRENT STEM CELL RESEARCH & THERAPY (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer
S Galper et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
